Join BJS Academy
BJS Academy>Randomized clinical ...>Routine end ischemic...
Normal View Dyslexic View

Routine end-ischemic hypothermic oxygenated machine perfusion in liver transplantation from donors after brain death. A randomized controlled trial.

24 January 2024
Randomized clinical trials Transplantation
Grąt M, Morawski M, Zhylko A, Rykowski P, Krasnodębski M, Wyporski A et al.

Ann Surg 2023; 278: 662-668.

Some 104 liver transplantations were included. Early allograft function was similar after both methods (P=0.24). Also, complication rates and other outcomes were similar.

Comment: This was a relatively small study that only included 26 livers that had machine perfusion. Nevertheless the result was disappointing.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct046
Randomized clinical trials
Randomized clinical trials
Transplantation
Routine end-ischemic hypothermic oxygenated machine perfusion in liver transplantation from donors after brain death. A randomized controlled trial.
Grąt M, Morawski M, Zhylko A, Rykowski P, Krasnodębski M, Wyporski A et al.
24012024
Ann Surg 2023; 278: 662-668.
Some 104 liver transplantations were included. Early allograft function was similar after both methods (P=0.24). Also, complication rates and other outcomes were similar.
Comment: This was a relatively small study that only included 26 livers that had machine perfusion. Nevertheless the result was disappointing.
Published on: 24 January 2024
Article ID: rct046

Related articles

Ex vivo kidney machine perfusion: meta-analysis of randomized clinical trials

Kang M, Kim S, Choi JY, Kim KS, Jung YK, Park B et al. 

20 May 2024

Temporary portocaval shunt provides superior intraoperative hemodynamics and reduces blood loss and duration of surgery in live donor liver transplantation. A randomized controlled trial.

Kumar M, Patil NS, Mohapatra N, Sindwani G, Dhingra U, Yadav A et al.
Ann Surg 2024; 279: 932-944.

16 August 2024

Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant. The OCS Liver PROTECT randomized clinical trial.

Markmann JF, Aboulijoud MS, Ghobrial RM, Bhati CS, Pelletier SJ, Lu AD et al.

2 May 2022
Home
  • Normal view
  • Dyslexic view
Info
Copied!